Cargando…

Postpartum Treatment for Substance Use Disorder Among Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Substance Exposure

Background: Little is known about rates of substance use disorder (SUD) treatment for women in dyads affected by substance use in the immediate postpartum period. This study's objectives were to (1) identify characteristics of mothers of infants with neonatal abstinence syndrome (NAS) and/or pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faherty, Laura J., Heins, Sara, Kranz, Ashley M., Stein, Bradley D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243701/ https://www.ncbi.nlm.nih.gov/pubmed/34235503 http://dx.doi.org/10.1089/whr.2020.0128

Ejemplares similares

Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome
por: Faherty, Laura J., et al.
Publicado: (2019)

State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome
por: Kroelinger, Charlan D., et al.
Publicado: (2019)

Neonatal Abstinence Syndrome in Infants with Prenatal Exposure to Methadone versus Buprenorphine
por: Kushnir, Alla, et al.
Publicado: (2023)

Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016–2020 Transformed Medicaid Statistical Information System
por: West, Kristina D., et al.
Publicado: (2023)

Use of Phenobarbital to Treat Neonatal Abstinence Syndrome From Exposure to Single vs. Multiple Substances
por: Kushnir, Alla, et al.
Publicado: (2022)

Neonatal Abstinence Syndrome: An Insight Over Impact of Maternal Substance Use
por: Dumbhare, Omkar, et al.
Publicado: (2023)

Prenatal exposure to perfluoroalkyl substances and inflammatory biomarker concentrations
por: Palaniyandi, Jana, et al.
Publicado: (2023)

Prenatal exposure to perfluoroalkyl substances: Infant birth weight and early life growth
por: Shoaff, Jessica, et al.
Publicado: (2018)

Neonatal Adaptation in Infants Prenatally Exposed to Antidepressants- Clinical Monitoring Using Neonatal Abstinence Score
por: Forsberg, Lisa, et al.
Publicado: (2014)

Preconception care, prenatal care, and postpartum bonding in women with substance use
por: Ghaemmaghami, Parvin, et al.
Publicado: (2023)

Medicaid expansion in Oregon and postpartum healthcare among people with and without prenatal substance use disorder()
por: Haight, Sarah C., et al.
Publicado: (2022)

Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy
por: Huang, Rong, et al.
Publicado: (2019)

Circadian Rhythmic Characteristics in Men With Substance Use Disorder Under Treatment. Influence of Age of Onset of Substance Use and Duration of Abstinence
por: Capella, Maria del Mar, et al.
Publicado: (2018)

Prenatal Exposure to Perfluoroalkyl Substances and Behavioral Development in Children
por: Quaak, Ilona, et al.
Publicado: (2016)

Definitions of neonatal abstinence syndrome in clinical studies of mothers and infants: an expert literature review
por: Jilani, Shahla M., et al.
Publicado: (2021)

Fostering Hope: Comprehensive Accessible Mother-Infant Dyad Care for Neonatal Abstinence (CAIN)
por: Clarke, Denise, et al.
Publicado: (2022)

Faith-based intervention, change of religiosity, and abstinence of substance addicts
por: Yeung, Jerf W.K.
Publicado: (2021)

Prenatal Exposure to Perfluoroalkyl Substances and Child Behavior at Age 12: A PELAGIE Mother–Child Cohort Study
por: Tillaut, Hélène, et al.
Publicado: (2023)

Pregnancy complications, substance abuse, and prenatal care predict birthweight in adolescent mothers
por: Hacker, Miriam, et al.
Publicado: (2021)

Mediation effects of DNA methylation and hydroxymethylation on birth outcomes after prenatal per- and polyfluoroalkyl substances (PFAS) exposure in the Michigan mother–infant Pairs cohort
por: Petroff, Rebekah L., et al.
Publicado: (2023)

Prevalence of prenatal exposure to substances of abuse: questionnaire versus biomarkers
por: Chiandetti, Antonella, et al.
Publicado: (2017)

Prenatal Exposure to Perfluoroalkyl Substances and Adiposity in Early and Mid-Childhood
por: Mora, Ana María, et al.
Publicado: (2016)

Dietary predictors of prenatal per- and poly-fluoroalkyl substances exposure
por: Eick, Stephanie M., et al.
Publicado: (2021)

A qualitative assessment of an abstinence-oriented therapeutic community for prisoners with substance use disorders in Kyrgyzstan
por: Azbel, Lyuba, et al.
Publicado: (2017)

Infants, children, and youth in foster care with prenatal substance exposure: a synthesis of two scoping reviews
por: Marcellus, Lenora, et al.
Publicado: (2021)

Top-Down Network Effective Connectivity in Abstinent Substance Dependent Individuals
por: Regner, Michael F., et al.
Publicado: (2016)

Prenatal Exposure to Per- and Polyfluoroalkyl Substances, Maternal Thyroid Dysfunction, and Child Autism Spectrum Disorder
por: Shin, Hyeong-Moo, et al.
Publicado: (2022)

Identification of Substance-Exposed Newborns and Neonatal Abstinence Syndrome Using ICD-10-CM — 15 Hospitals, Massachusetts, 2017
por: Goyal, Sonal, et al.
Publicado: (2020)

Three-Year Custody Outcomes Among Infants Investigated by Child Protection Systems for Prenatal Substance Exposure in California
por: Reddy, Julia, et al.
Publicado: (2023)

Determination of Prenatal Substance Exposure Using Meconium and Orbitrap Mass Spectrometry
por: Hernandez, Atakan, et al.
Publicado: (2022)

Integrated substance use and prenatal care delivery in the era of COVID-19
por: Patton, Elizabeth W., et al.
Publicado: (2021)

Factors Associated with Maternal Engagement in Infant Care When Mothers Use Substances
por: Renbarger, Kalyn M., et al.
Publicado: (2023)

Personality of mothers of substance-dependent patients
por: Baron, David, et al.
Publicado: (2010)

Prevention of postpartum smoking relapse in mothers of infants in the neonatal intensive care unit
por: Phillips, R M, et al.
Publicado: (2012)

Prenatal substance use policies and newborn health
por: Meinhofer, Angélica, et al.
Publicado: (2022)

High degree of uncertain reflective functioning in mothers with substance use disorder
por: Handeland, Tore Bergby, et al.
Publicado: (2019)

Patterns of adverse childhood experiences and associations with prenatal substance use and poor infant outcomes in a multi-country cohort of mothers: a latent class analysis
por: Hemady, Chad Lance, et al.
Publicado: (2022)

Placental Transfer of Perfluoroalkyl Substances and Associations with Thyroid Hormones: Beijing Prenatal Exposure Study
por: Yang, Lin, et al.
Publicado: (2016)

Prenatal Perfluoroalkyl Substance Exposure and Child Adiposity at 8 Years of Age: The HOME Study
por: Braun, Joseph M., et al.
Publicado: (2015)

Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Child Growth Trajectories in the First Two Years
por: Gao, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1d88eo1dmq29on7e1j33hitohp